Stay updated on Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial

Sign up to get notified when there's something new on the Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a visible 403 label and a Home button, indicating that access to the page is blocked. This reflects an access-control state change rather than updates to the page's substantive content.
    Difference
    0.5%
    Check dated 2026-09-27T20:00:28.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, preventing access to the study record and related documents. The visible page chrome remains, but the main study content is inaccessible.
    Difference
    16%
    Check dated 2026-09-20T19:46:47.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The site revision was updated to v3.6.6, representing a newer version of the ClinicalTrials.gov interface. This change likely includes minor fixes or improvements and does not alter the study content displayed on the page.
    Difference
    0.0%
    Check dated 2026-08-30T15:46:18.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.4 to v3.6.5 on the page's history, indicating a minor maintenance update to the page documentation. The change does not alter study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-08-08T23:53:50.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    The page shows a new revision tag, updating from v3.6.3 to v3.6.4, indicating a minor version update. There are no evident changes to the study details or user-facing content beyond the revision metadata.
    Difference
    0.0%
    Check dated 2026-07-25T13:13:22.000Z thumbnail image
  7. Check
    98 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3, replacing v3.6.2, signaling a minor platform update; study content remains unchanged.
    Difference
    0.0%
    Check dated 2026-07-04T03:56:28.000Z thumbnail image

Stay in the know with updates to Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial page.